Product Information
CEFADROXIL 1 GM TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $3.3737 per EA under NDC 00093405953. Its NADAC has been published 189 times since Feb 22, 2023.
FDA first approved this application on Apr 8, 1987.
The High Outlier badge above means this manufacturer's average price in the Cefadroxil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1000 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093405953
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEFADROXILApproval Type
Generic (ANDA)
FDA Application
ANDA062774FDA Approved
4/8/1987
On Market Since
1/31/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFADROXIL 1 GM TABLET has been published 189 times since Feb 22, 2023, and over the history we have for it it has risen 23.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3737 per EA |
|---|---|
| All-time high | $4.1937 (Mar 13, 2024) |
| All-time low | $2.7312 (Feb 22, 2023) |
| 52-week high | $4.1752 |
| 52-week low | $3.3737 |
| Median price | $3.4346 |
| Average price | $3.4467 |
| Largest weekly change | +30.4% (Sep 20, 2023) |
| Weeks tracked | 189 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cefadroxil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cefadroxil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFADROXIL 1 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CEFADROXIL 1 GM TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $3.3737 per EA (NDC 00093405953), effective Sep 30, 2026.
How has the price of CEFADROXIL 1 GM TABLET changed over time?
Over the history we have for it, the NADAC for CEFADROXIL 1 GM TABLET has risen 23.5%. It has been tracked across 189 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for CEFADROXIL 1 GM TABLET?
Since Feb 22, 2023, the NADAC for CEFADROXIL 1 GM TABLET has ranged from a low of $2.7312 (Feb 22, 2023) to a high of $4.1937 (Mar 13, 2024), with a median of $3.4346 per EA.
Are there cheaper alternatives to CEFADROXIL 1 GM TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CEFADROXIL 1 GM TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CEFADROXIL 1 GM TABLET?
CEFADROXIL 1 GM TABLET (NDC 00093405953) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.